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INTRODUCTION 
A collision tumor consists of two independent neoplasms 
growing in close proximity until they become juxtaposed, 
appearing as one lesion. This is a very rare situation with 
unclear physiopathology. Collision tumors should be 
distinguished from composite tumors, which consist of 
one neoplastic clone that diverges into two cell lineages. 
Collisions located in the esophagus are particularly 
uncommon.
CASE REPORT
A 51-year-old male patient, a former smoker and 
former alcoholic, presented with a glottic squamous 
cell carcinoma and underwent a total laringectomy with 
selective neck dissection (II, III, and IV). A pathological 
analysis of the surgical specimen confirmed a T2N0 
squamous cell carcinoma, and adjuvant radiotherapy was 
performed (total dosage 6000 cGy). Six months later, 
the patient presented with progressive dysphagia, and 
an upper digestive endoscopy revealed an infiltrative 
tumor, approximately 2 cm long, in the distal esophagus. 
Biopsies revealed a poorly differentiated squamous cell 
carcinoma with areas of neuroendocrine differentiation. A 
Positron emission tomography scan demonstrated no extra-
esophageal disease. 
The patient then underwent a subtotal esophagectomy 
with thoracic and abdominal lymphadenectomy (Ivor-
Lewis procedure). Reconstruction was performed with 
an intrathoracic esophagogastric end-to-side mechanical 
anastomosis. 
The surgical specimen revealed a lesion that was 
2.5 cm wide, located 2 cm above the esophagogastric 
junction. Microscopy confirmed an in situ proliferation 
of squamous cells with abundant eosinophilic cytoplasm 
and high mitotic count with severe atypia in the nuclei. 
In very intimate contact with these squamous cells, there 
was another component of the tumor with a higher nuclei/
cytoplasm ratio, nuclei with a “salt and pepper” appearance 
and a very noticeably invasive behavior. Immunostaining 
of the tumor revealed that this second component exhibited 
neuroendocrine differentiation, being negative for p63 (the 
squamous component was p63-positive), strongly positive 
for Ki-67 (60%), positive for synaptophysin and CD56, and 
focally positive for chromogranin A. The neuroendocrine 
component also exhibited a high mitotic rate (17 mitoses per 
10 high power fields).
The interface between the two components of the 
tumor was abrupt. The squamous cell carcinoma was in 
situ, whereas the neuroendocrine carcinoma invaded the 
submucosal layer. Neural and vascular invasions were 
absent. The surgical margins were free, and there was no 
lymph node involvement (0/11 dissected).
The postoperative course was uneventful, and the patient 
was discharged on the 12th day after the procedure. He 
remains asymptomatic and disease-free after a follow-up of 
26 months.
DISCUSSION
Collision tumors are rare lesions derived from two 
different histogenetic events.1 Two independent tumors 
grow in proximity until they become juxtaposed. They may 
be hard to differentiate from mixed or composite tumors, 
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Panel: The exophytic ulcerated lesion in the distal esophagus (A) and its corresponding histopathology (B-E). B – Low-magnification image showing the 
squamous “in situ” component (arrowheads) and the neuroendocrine, nest-arranged component (asterisks). C – High-magnification image of the squamous 
cell component. D – High-magnification image of the neuroendocrine component with typical “salt and pepper” nuclei. E – Cheratin immunostaining show-
ing the squamous component (positive in brown - arrowheads) and the neuroendocrine component (negative – asterisks). F – High-magnification image of 
a CD56-positive neuroendocrine area. G – High-magnification image showing Ki-67 positiveness.
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when one mutated cell diverges into two clones resulting 
in two different neoplasms.1-3 Histopathological analysis, 
immunohistochemical analysis, microsatellite instability 
research and electron microscopy can all help distinguish 
between these two situations. 
In the present case, the microscopic findings 
demonstrated an abrupt transition between the two 
components, this is expected for collision tumors, differing 
them from composite tumors in which the two components 
intermingle. The immunohistochemical analysis revealed a 
pattern compatible with a neuroendocrine component located 
next to the squamous “in situ” component. 
The physiopathology of collision tumors is still unclear, 
but recent data suggest that the proposed accidental meeting 
of two independent tumors is not in accord with what is 
known today about carcinogenesis. The field effect of 
carcinogens probably plays a major etiological role in the 
process, and the present patient is a good example of this. 
Mucosal exposure to alcohol and smoke probably initiated 
various cells in his respiratory and upper digestive tracts, 
allowing further mutations to originate two squamous cell 
carcinomas (glottic and esophageal).7 
It is also known that a neoplasm’s surrounding area 
is altered, influencing cancer growth and contributing to 
epithelial instability.8-10 Therefore, it is plausible that a pool 
of initiated cells in an area may be stimulated by an altered 
microenvironment, ultimately resulting in a second neoplasm 
that can grow until it collides with the first tumor. Although 
knowing which component appeared first in this case is 
impossible, it is probable that the first neoplasm contributed 
to the rise and growth of the second.
With respect to the risk factors for neuroendocrine 
tumors, their occurrence is mainly attributed to genetic 
alterations.11 According to the most recent World Health 
Organization classification, neuroendocrine tumors can 
be separated into three main categories with distinguished 
histology and prognosis: well-differentiated neuroendocrine 
tumors have a low malignant potential, well-differentiated 
neuroendocrine carcinomas are more aggressive lesions 
with metastatic potential, and poorly differentiated 
neuroendocrine carcinomas are high grade malignancies 
with poor prognosis.12 The present case was classified as a 
well-differentiated neuroendocrine carcinoma. 
With regard to prognosis, for in situ squamous cell 
carcinomas a five-year survival rate greater than 85% 
can be expected.13 There is no specific staging system for 
neuroendocrine carcinomas, and some authors prefer not to 
use the TNM system (International Union Against Cancer), 
instead relying on the framework recommended by the 
Veterans Administration Lung Study Group, which classifies 
lesions into two categories: limited disease (tumor contained 
within a localized anatomic region, independent of regional 
lymphatic involvement) and extensive disease (tumor 
outside locoregional boundaries). Treatment for the limited 
disease is potentially curative, and surgery represents the 
best chance for a cure.14 Also, the best predictor of survival 
for neuroendocrine tumor cases seems to be the Ki-67 score 
and not the degree of differentiation or the tumor site, as 
expected.12
It should be also noted that the esophageal lesion was 
probably present at the time of the first operation. Although 
it was not diagnosed at that time, this situation underscores 
the importance of a full investigation of the airways 
and upper digestive tract in patients with squamous cell 
carcinoma in one of these tracts. The assessment should 
include an upper digestive endoscopy with chromoscopy.
As for the surgical choice, a cervical approach was not 
considered since the patient had severe surgical and actinic 
alterations in this region.
Esophageal collisions are particularly uncommon and 
usually occur in association with Barrett`s esophagus.4-6 
To our knowledge, this is the first report of an esophageal 
collision between a squamous cell carcinoma and a 
neuroendocrine carcinoma.
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